Medicine
Valproic acid 250 mg capsule
Valproic acid 250 mg capsule is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store capsules at controlled room temperature 15° to 30°C (59° to 86°F), see…
Key facts
- Active ingredient (INN)
- Valproic acid
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 60 capsules, 90 capsules and 25 more
- Manufacturers
- Aphena Pharma Solutions - TennesseeRemedyrepackActavis PharmaAtlantic BiologicalsBionpharmaBryant Ranch PrepackDirect_RxUpsher-Smith LaboratoriesVangard Labs
- Origin register
- US FDA, United States
- Storage
- Store capsules at controlled room temperature 15° to 30°C (59° to 86°F), see USP.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AG01 Valproic acid
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 September 2009
- Identifiers
- RxCUI 1099681DailyMed set ID 34a0d45a-4388-7d8b-e063-6394a90a6c3f, cef3e335-5891-412f-89c4-79fcd2f145b7, 3798f957-8b32-4ac0-8fd1-80283414c255 +8NDC 71610-906, 0591-4012, 43353-279 +8Application ANDA073229, ANDA073484
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule, liquid filled in 1 bottle | 0591-4012-01 | Actavis Pharma | 8 September 2009 |
| 100 capsule, liquid filled in 1 bottle, plastic | 69452-150-20 | Bionpharma | 15 July 2016 |
| 100 capsule in 1 bottle | 0832-0310-11 | Upsher-Smith Laboratories | 9 February 2015 |
| 60 capsule in 1 bottle | 43353-085-53 | Aphena Pharma Solutions - Tennessee | 20 July 2015 |
| 90 capsule in 1 bottle | 43353-085-60 | Aphena Pharma Solutions - Tennessee | 20 July 2015 |
| 120 capsule in 1 bottle | 43353-085-70 | Aphena Pharma Solutions - Tennessee | 16 December 2015 |
| 180 capsule in 1 bottle | 43353-085-80 | Aphena Pharma Solutions - Tennessee | 15 December 2015 |
| 240 capsule in 1 bottle | 43353-085-90 | Aphena Pharma Solutions - Tennessee | 23 May 2016 |
| 360 capsule in 1 bottle | 43353-085-94 | Aphena Pharma Solutions - Tennessee | 28 October 2015 |
| 60 capsule, liquid filled in 1 bottle, plastic | 43353-279-53 | Aphena Pharma Solutions - Tennessee | 11 February 2017 |
| 90 capsule, liquid filled in 1 bottle, plastic | 43353-279-60 | Aphena Pharma Solutions - Tennessee | 11 February 2017 |
| 120 capsule, liquid filled in 1 bottle, plastic | 43353-279-70 | Aphena Pharma Solutions - Tennessee | 16 February 2017 |
| 180 capsule, liquid filled in 1 bottle, plastic | 43353-279-80 | Aphena Pharma Solutions - Tennessee | 11 February 2017 |
| 240 capsule, liquid filled in 1 bottle, plastic | 43353-279-90 | Aphena Pharma Solutions - Tennessee | 25 April 2017 |
| 360 capsule, liquid filled in 1 bottle, plastic | 43353-279-94 | Aphena Pharma Solutions - Tennessee | 7 March 2017 |
| 30 capsule, liquid filled in 1 bottle | 71610-906-30 | Aphena Pharma Solutions - Tennessee | 7 May 2025 |
| 60 capsule, liquid filled in 1 bottle | 71610-906-53 | Aphena Pharma Solutions - Tennessee | 7 May 2025 |
| 90 capsule, liquid filled in 1 bottle | 71610-906-60 | Aphena Pharma Solutions - Tennessee | 7 May 2025 |
| 120 capsule, liquid filled in 1 bottle | 71610-906-70 | Aphena Pharma Solutions - Tennessee | 23 May 2025 |
| 180 capsule, liquid filled in 1 bottle | 71610-906-80 | Aphena Pharma Solutions - Tennessee | 7 May 2025 |
| 240 capsule, liquid filled in 1 bottle | 71610-906-90 | Aphena Pharma Solutions - Tennessee | 23 May 2025 |
| 100 pouch in 1 box, unit-dose / 1 capsule, liquid filled in 1 pouch | 17856-0152-1 | Atlantic Biologicals | 25 June 2021 |
| 100 capsule, liquid filled in 1 bottle, plastic | 63629-2454-1 | Bryant Ranch Prepack | 24 January 2025 |
| 30 capsule in 1 bottle | 72189-010-30 | Direct_Rx | 21 June 2019 |
| 30 capsule, liquid filled in 1 blister pack | 70518-0079-0 | Remedyrepack | 23 December 2016 |
| 100 pouch in 1 box / 1 capsule, liquid filled in 1 pouch | 70518-0079-1 | Remedyrepack | 11 June 2020 |
| 50 pouch in 1 box / 1 capsule, liquid filled in 1 pouch | 70518-0079-3 | Remedyrepack | 23 April 2026 |
| 30 capsule, liquid filled in 1 blister pack | 0615-8205-39 | Vangard Labs | 5 March 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 February 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Valproic acid
Clinical summary
Valproic acid is an anti-epileptic agent indicated for monotherapy and adjunctive therapy of complex partial seizures, sole and adjunctive therapy of simple and complex absence seizures, among other approved uses. MedsAcross supplies Valproic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Valproic acidFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VALPROIC ACID prescribing information (PAI Pharma) · U.S. National Library of Medicine, DailyMed
Need Valproic acid 250 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.